\-\ Texto\\:\\ \ \(0\)\
\-\ aao\\,\\ nad\ \(0\)\
\-\ perrl\\,\\ eomi\ \(0\)\
\-\ face\\ symmetric\\,\\ tongue\\ midline\ \(0\)\
\-\ mild\\ right\\ uvular\\ deviation\ \(0\)\
\-\ speech\\:\\ fluent\\,\\ naming\\,\\ comprehension\\ intact\ \(0\)\
\-\ neg\\ drift\ \(0\)\
\-\ right\\:\\ \\ \\ 5\\ 5\\ 5\\ 5\\ 5\\ \\|\\ \\ 5\\ \\ 5\\ \\ 5\\ \\ 5\\ \\ 5\ \(0\)\
\-\ left\\:\\ \\ \\ \\ \\ 5\\ 5\\ 5\\ 5\\ 5\\ \\|\\ \\ 5\\ \\ 5\\ \\ 5\\ \\ 5\\ \\ 5\ \(0\)\
\-\ mild\\ dysmetria\\ rue\\ ftf\ \(0\)\
\-\ scheduled\\ for\\ right\\ frontal\\ craniotomy\\,\\ stealth\\-guided\\ resection\\ of\\ frontal\\ lesions\ \(0\)\
\-\ frozen\\ of\\ medial\\ lesion\\ sent\\ \\(specimen\\ appeared\\ to\\ be\\ glial\\ in\\ nature\\)\ \(0\)\
\-\ complete\\ resection\\ of\\ lesions\\ ensued\ \(0\)\
\-\ two\\ enhancing\\ right\\ frontal\\ lesions\\ w\\/o\\ significant\\ surrounding\\ vasogenic\\ edema\ \(0\)\
\-\ astrocytoma\\ who\\ gr\\ 4\\ \\(glioblastoma\\)\\,\\ multifocal\ \(0\)\
\-\ prostate\\ metastasis\ \(0\)\
\-\ cns\\ lymphoma\ \(0\)\
\-\ metastasis\\ from\\ unkown\\ 2nd\\ primary\ \(0\)\
\-\ multi\\-focal\\ glioma\ \(0\)\
\-\ 69\\ y\\.o\\.\\ rhd\\ man\\ with\\ new\\ onset\\ seizure\\ \\(left\\)\\.\ \(0\)\
\-\ presented\\ to\\ local\\ er\\ after\\ seizure\\,\\ became\\ unresponsive\\,\\ and\\ was\\ intubated\\.\\ \\ screening\\ ct\\ was\\ abnormal\\.\ \(0\)\
\-\ later\\,\\ he\\ was\\ extubated\\ and\\ discharged\\ on\\ aed\\ \\(anti\\-epileptic\\ drugs\\)\\.\\ \\ he\\ was\\ readmitted\\ for\\ fevers\\ and\\ uti\\ 4\\ days\\ later\\.\ \(0\)\
\-\ pmh\\/psh\\:\\ \ \(0\)\
\-\ prostate\\ ca\\ 3\\+3\\,\\ stable\\ on\\ recent\\ trus\\ fusion\ \(0\)\
\-\ osa\ \(1167\)\
\-\ htn\ \(15\)\
\-\ meds\\:\\ \\ keppra\\,\\ benezapril\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ 5\\:\\ 0\\.2631747813099119\ \(0\)\
\-\ \\|\\:\\ 0\\.07231166605169669\ \(0\)\
\-\ prostate\\:\\ 0\\.04777739268368887\ \(0\)\
\-\ uvular\\:\\ 0\\.04639746538929736\ \(0\)\
\-\ ftf\\:\\ 0\\.04639746538929736\ \(0\)\
\-\ stealth\\-guided\\:\\ 0\\.04639746538929736\ \(0\)\
\-\ ensued\\:\\ 0\\.04639746538929736\ \(0\)\
\-\ aed\\:\\ 0\\.04639746538929736\ \(0\)\
\-\ 3\\+3\\:\\ 0\\.04639746538929736\ \(0\)\
\-\ trus\\:\\ 0\\.04639746538929736\ \(0\)\
\-\ benezapril\\:\\ 0\\.04639746538929736\ \(0\)\
\-\ anti\\-epileptic\\:\\ 0\\.0427493223337187\ \(0\)\
\-\ osa\\:\\ 0\\.0427493223337187\ \(0\)\
\-\ frontal\\:\\ 0\\.04238355686026354\ \(0\)\
\-\ naming\\:\\ 0\\.04061529544893888\ \(0\)\
\-\ unkown\\:\\ 0\\.04061529544893888\ \(0\)\
\-\ multi\\-focal\\:\\ 0\\.04061529544893888\ \(0\)\
\-\ seizure\\:\\ 0\\.03977437706897757\ \(0\)\
\-\ aao\\:\\ 0\\.03910117927814004\ \(0\)\
\-\ rhd\\:\\ 0\\.03910117927814004\ \(0\)\
\-\ comprehension\\:\\ 0\\.03792673953438104\ \(0\)\
\-\ pmh\\/psh\\:\\ 0\\.03792673953438104\ \(0\)\
\-\ keppra\\:\\ 0\\.03696715239336022\ \(0\)\
\-\ rue\\:\\ 0\\.03615583302584834\ \(0\)\
\-\ readmitted\\:\\ 0\\.03615583302584834\ \(0\)\
\-\ lesions\\:\\ 0\\.03611937641595707\ \(0\)\
\-\ fluent\\:\\ 0\\.03545303622256138\ \(0\)\
\-\ dysmetria\\:\\ 0\\.03545303622256138\ \(0\)\
\-\ extubated\\:\\ 0\\.03483312550858041\ \(0\)\
\-\ glial\\:\\ 0\\.03427859647880238\ \(0\)\
\-\ drift\\:\\ 0\\.03377696395351646\ \(0\)\
\-\ frozen\\:\\ 0\\.03377696395351646\ \(0\)\
\-\ metastasis\\:\\ 0\\.03367102448736765\ \(0\)\
\-\ later\\:\\ 0\\.03247809095782025\ \(0\)\
\-\ perrl\\:\\ 0\\.03180489316698272\ \(0\)\
\-\ gr\\:\\ 0\\.03180489316698272\ \(0\)\
\-\ \\:\\:\\ 0\\.0297440741050175\ \(0\)\
\-\ unresponsive\\:\\ 0\\.029249588873394818\ \(0\)\
\-\ uti\\:\\ 0\\.028496426538443906\ \(0\)\
\-\ 69\\:\\ 0\\.028323848523586062\ \(0\)\
\-\ resection\\:\\ 0\\.02805174374231809\ \(0\)\
\-\ eomi\\:\\ 0\\.027685107170932022\ \(0\)\
\-\ meds\\:\\ 0\\.027685107170932022\ \(0\)\
\-\ neg\\:\\ 0\\.027536839397423095\ \(0\)\
\-\ tongue\\:\\ 0\\.02739263427011723\ \(0\)\
\-\ craniotomy\\:\\ 0\\.02698231036764506\ \(0\)\
\-\ specimen\\:\\ 0\\.02698231036764506\ \(0\)\
\-\ intubated\\:\\ 0\\.026725520029911208\ \(0\)\
\-\ speech\\:\\ 0\\.02591420066239932\ \(0\)\
\-\ w\\/o\\:\\ 0\\.025402812512643282\ \(0\)\
\-\ deviation\\:\\ 0\\.025118248190168148\ \(0\)\
\-\ he\\:\\ 0\\.025096708863505467\ \(0\)\
\-\ 4\\:\\ 0\\.025062862159779424\ \(0\)\
\-\ nad\\:\\ 0\\.024936742000319888\ \(0\)\
\-\ drugs\\:\\ 0\\.02484828348286525\ \(0\)\
\-\ glioblastoma\\:\\ 0\\.024761287156806245\ \(0\)\
\-\ htn\\:\\ 0\\.024761287156806245\ \(0\)\
\-\ appeared\\:\\ 0\\.024508607055825398\ \(0\)\
\-\ vasogenic\\:\\ 0\\.024346650957579326\ \(0\)\
\-\ became\\:\\ 0\\.024267504234608064\ \(0\)\
\-\ multifocal\\:\\ 0\\.024189530098896798\ \(0\)\
\-\ mild\\:\\ 0\\.02368687846243302\ \(0\)\
\-\ cns\\:\\ 0\\.023015090355137796\ \(0\)\
\-\ sent\\:\\ 0\\.02289268581743113\ \(0\)\
\-\ scheduled\\:\\ 0\\.022656099565524467\ \(0\)\
\-\ 2nd\\:\\ 0\\.022429692275610303\ \(0\)\
\-\ face\\:\\ 0\\.02205550321411698\ \(0\)\
\-\ fevers\\:\\ 0\\.021378569646632282\ \(0\)\
\-\ nature\\:\\ 0\\.02128859894474123\ \(0\)\
\-\ ca\\:\\ 0\\.02094335008955274\ \(0\)\
\-\ was\\:\\ 0\\.020805842572919724\ \(0\)\
\-\ local\\:\\ 0\\.020658785767077602\ \(0\)\
\-\ discharged\\:\\ 0\\.020619361179029405\ \(0\)\
\-\ symmetric\\:\\ 0\\.02054138704331814\ \(0\)\
\-\ glioma\\:\\ 0\\.020277230493192584\ \(0\)\
\-\ fusion\\:\\ 0\\.02006090588432126\ \(0\)\
\-\ screening\\:\\ 0\\.019184391731201823\ \(0\)\
\-\ right\\:\\ 0\\.018981720191798244\ \(0\)\
\-\ stable\\:\\ 0\\.018537966311800033\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.017465001045648926\ \(0\)\
\-\ midline\\:\\ 0\\.01740068467020274\ \(0\)\
\-\ er\\:\\ 0\\.017253600826041902\ \(0\)\
\-\ \\,\\:\\ 0\\.017097477822144467\ \(0\)\
\-\ intact\\:\\ 0\\.016519813798411664\ \(0\)\
\-\ complete\\:\\ 0\\.015828294389400286\ \(0\)\
\-\ new\\:\\ 0\\.015672568298950307\ \(0\)\
\-\ \\(\\:\\ 0\\.015207615289344431\ \(0\)\
\-\ recent\\:\\ 0\\.01511957394126209\ \(0\)\
\-\ \\)\\:\\ 0\\.015021846149753791\ \(0\)\
\-\ surrounding\\:\\ 0\\.014785080338761922\ \(0\)\
\-\ medial\\:\\ 0\\.014385786913631852\ \(0\)\
\-\ onset\\:\\ 0\\.014196953820658683\ \(0\)\
\-\ enhancing\\:\\ 0\\.014105018594130311\ \(0\)\
\-\ days\\:\\ 0\\.013784601558799882\ \(0\)\
\-\ primary\\:\\ 0\\.013323075067872087\ \(0\)\
\-\ y\\.o\\:\\ 0\\.012980944382035264\ \(0\)\
\-\ two\\:\\ 0\\.012880690724294767\ \(0\)\
\-\ lymphoma\\:\\ 0\\.012853677023102555\ \(0\)\
\-\ abnormal\\:\\ 0\\.012826801264815323\ \(0\)\
\-\ edema\\:\\ 0\\.012720649944375214\ \(0\)\
\-\ presented\\:\\ 0\\.012259777026433733\ \(0\)\
\-\ significant\\:\\ 0\\.012093932373969597\ \(0\)\
\-\ who\\:\\ 0\\.01172614952179843\ \(0\)\
\-\ man\\:\\ 0\\.010636483384684207\ \(0\)\
\-\ left\\:\\ 0\\.01006426599234647\ \(0\)\
\-\ after\\:\\ 0\\.009305269487416855\ \(0\)\
\-\ lesion\\:\\ 0\\.00916081697894976\ \(0\)\
\-\ for\\:\\ 0\\.007674822617291738\ \(0\)\
\-\ on\\:\\ 0\\.007619905393320295\ \(0\)\
\-\ be\\:\\ 0\\.006935561701810153\ \(0\)\
\-\ from\\:\\ 0\\.006665451121864275\ \(0\)\
\-\ ct\\:\\ 0\\.006291071859958121\ \(0\)\
\-\ to\\:\\ 0\\.0044954537730840655\ \(0\)\
\-\ and\\:\\ 0\\.0028422474589297653\ \(0\)\
\-\ in\\:\\ 0\\.002217880158632921\ \(0\)\
\-\ of\\:\\ 0\\.0018395336968103438\ \(0\)\
\-\ \\.\\:\\ 0\\.0011210379820214614\ \(0\)\
\-\ with\\:\\ 0\\.0006158114531046829\ \(0\)\
